HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:DOC • US42250P1030
16.85 USD
+0.17 (+1.02%)
At close: Feb 6, 2026
16.7735 USD
-0.08 (-0.45%)
After Hours: 2/6/2026, 8:04:00 PM
We assign a fundamental rating of 4 out of 10 to DOC. DOC was compared to 124 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DOC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year DOC was profitable.
- In the past year DOC had a positive cash flow from operations.
- Each year in the past 5 years DOC has been profitable.
- DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- DOC has a Return On Assets (0.35%) which is comparable to the rest of the industry.
- DOC has a Return On Equity (0.94%) which is comparable to the rest of the industry.
- Looking at the Return On Invested Capital, with a value of 2.24%, DOC is in line with its industry, outperforming 41.94% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for DOC is in line with the industry average of 3.05%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROIC | 2.24% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
1.3 Margins
- DOC has a Profit Margin (2.50%) which is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of DOC has declined.
- DOC's Operating Margin of 19.31% is in line compared to the rest of the industry. DOC outperforms 45.97% of its industry peers.
- DOC's Operating Margin has improved in the last couple of years.
- DOC's Gross Margin of 60.00% is on the low side compared to the rest of the industry. DOC is outperformed by 66.94% of its industry peers.
- DOC's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% |
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
- The number of shares outstanding for DOC has been reduced compared to 1 year ago.
- DOC has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for DOC is higher compared to a year ago.
2.2 Solvency
- DOC has an Altman-Z score of 0.32. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of 0.32, DOC is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
- The Debt to FCF ratio of DOC is 6154.93, which is on the high side as it means it would take DOC, 6154.93 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of DOC (6154.93) is better than 61.29% of its industry peers.
- DOC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
- DOC has a Debt to Equity ratio of 1.27. This is comparable to the rest of the industry: DOC outperforms 50.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 6154.93 | ||
| Altman-Z | 0.32 |
ROIC/WACC0.38
WACC5.98%
2.3 Liquidity
- A Current Ratio of 0.48 indicates that DOC may have some problems paying its short term obligations.
- DOC has a Current ratio of 0.48. This is amonst the worse of the industry: DOC underperforms 80.65% of its industry peers.
- DOC has a Quick Ratio of 0.48. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.48, DOC is doing worse than 80.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 |
3. Growth
3.1 Past
- DOC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
- Measured over the past years, DOC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.06% on average per year.
- The Revenue has been growing slightly by 4.52% in the past year.
- The Revenue has been growing by 11.40% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
3.2 Future
- The Earnings Per Share is expected to grow by 1.32% on average over the next years.
- DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.02% yearly.
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y1.32%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.02%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 48.14, DOC can be considered very expensive at the moment.
- DOC's Price/Earnings is on the same level as the industry average.
- When comparing the Price/Earnings ratio of DOC to the average of the S&P500 Index (27.92), we can say DOC is valued expensively.
- A Price/Forward Earnings ratio of 63.82 indicates a quite expensive valuation of DOC.
- DOC's Price/Forward Earnings is on the same level as the industry average.
- DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 27.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.14 | ||
| Fwd PE | 63.82 |
4.2 Price Multiples
- DOC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOC is cheaper than 69.35% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOC indicates a somewhat cheap valuation: DOC is cheaper than 61.29% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7318.7 | ||
| EV/EBITDA | 13.08 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
5. Dividend
5.1 Amount
- DOC has a Yearly Dividend Yield of 7.31%, which is a nice return.
- DOC's Dividend Yield is a higher than the industry average which is at 6.82.
- Compared to an average S&P500 Dividend Yield of 1.81, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.31% |
5.2 History
- The dividend of DOC decreases each year by -4.20%.
- DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-4.2%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1204.15% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DP1204.15%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
16.85
+0.17 (+1.02%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.22%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change0.5%
Market Cap11.71B
Revenue(TTM)2.82B
Net Income(TTM)70.51M
Analysts75.83
Price Target20.27 (20.3%)
Short Float %3.7%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.31% |
Yearly Dividend1.22
Dividend Growth(5Y)-4.2%
DP1204.15%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)108.65%
Min EPS beat(2)37.75%
Max EPS beat(2)179.54%
EPS beat(4)3
Avg EPS beat(4)52.57%
Min EPS beat(4)-19.41%
Max EPS beat(4)179.54%
EPS beat(8)5
Avg EPS beat(8)31.44%
EPS beat(12)8
Avg EPS beat(12)38.23%
EPS beat(16)11
Avg EPS beat(16)56.93%
Revenue beat(2)2
Avg Revenue beat(2)1.99%
Min Revenue beat(2)0.94%
Max Revenue beat(2)3.04%
Revenue beat(4)3
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)3.04%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)9
Avg Revenue beat(12)-4.49%
Revenue beat(16)11
Avg Revenue beat(16)-3.26%
PT rev (1m)-2.61%
PT rev (3m)-5.03%
EPS NQ rev (1m)-0.82%
EPS NQ rev (3m)0.75%
EPS NY rev (1m)-1.12%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.14 | ||
| Fwd PE | 63.82 | ||
| P/S | 4.15 | ||
| P/FCF | 7318.7 | ||
| P/OCF | 9.35 | ||
| P/B | 1.56 | ||
| P/tB | 1.73 | ||
| EV/EBITDA | 13.08 |
EPS(TTM)0.35
EY2.08%
EPS(NY)0.26
Fwd EY1.57%
FCF(TTM)0
FCFY0.01%
OCF(TTM)1.8
OCFY10.69%
SpS4.06
BVpS10.79
TBVpS9.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.35% | ||
| ROE | 0.94% | ||
| ROCE | 2.84% | ||
| ROIC | 2.24% | ||
| ROICexc | 2.3% | ||
| ROICexgc | 2.51% | ||
| OM | 19.31% | ||
| PM (TTM) | 2.5% | ||
| GM | 60% | ||
| FCFM | 0.06% |
ROA(3y)1.17%
ROA(5y)1.99%
ROE(3y)2.87%
ROE(5y)4.76%
ROIC(3y)2.27%
ROIC(5y)2.16%
ROICexc(3y)2.3%
ROICexc(5y)2.18%
ROICexgc(3y)2.51%
ROICexgc(5y)2.37%
ROCE(3y)2.87%
ROCE(5y)2.73%
ROICexgc growth 3Y5.01%
ROICexgc growth 5Y15.76%
ROICexc growth 3Y4.44%
ROICexc growth 5Y15.37%
OM growth 3Y0.32%
OM growth 5Y7.81%
PM growth 3Y-53.06%
PM growth 5Y-36.91%
GM growth 3Y1.1%
GM growth 5Y2.84%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 6154.93 | ||
| Debt/EBITDA | 5.92 | ||
| Cap/Depr | 118.09% | ||
| Cap/Sales | 44.3% | ||
| Interest Coverage | 2.1 | ||
| Cash Conversion | 78.06% | ||
| Profit Quality | 2.27% | ||
| Current Ratio | 0.48 | ||
| Quick Ratio | 0.48 | ||
| Altman-Z | 0.32 |
F-Score6
WACC5.98%
ROIC/WACC0.38
Cap/Depr(3y)91.62%
Cap/Depr(5y)145.43%
Cap/Sales(3y)33.64%
Cap/Sales(5y)52.36%
Profit Quality(3y)87.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-24.56%
EPS Next 2Y-8.84%
EPS Next 3Y0.81%
EPS Next 5Y1.32%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y11.05%
Revenue growth 5Y11.4%
Sales Q2Q%3.07%
Revenue Next Year1.33%
Revenue Next 2Y1.76%
Revenue Next 3Y2.62%
Revenue Next 5Y5.02%
EBIT growth 1Y-3.69%
EBIT growth 3Y11.4%
EBIT growth 5Y20.1%
EBIT Next Year278.7%
EBIT Next 3Y62.79%
EBIT Next 5Y36.69%
FCF growth 1Y-99.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.95%
OCF growth 3Y11.62%
OCF growth 5Y10.54%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 4 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 5 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 48.14 and the Price/Book (PB) ratio is 1.56.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 1204.15%.